GlassScriptPhysician profile
Stephen T Duncan
NPI 1578726873
$789,333.75
in general payments reported to CMS, 2019-2025
19 companies · $241K in 2025
The $241K reported for 2025 was more than what 96% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60K · 2020: $66K · 2021: $64K · 2022: $63K · 2023: $123K · 2024: $173K · 2025: $241K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $281K · Consulting Fee: $145K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $75K · Travel and Lodging: $25K · Food and Beverage: $11K · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $280,516.99 |
| Consulting Fee | $144,793.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $75,362.50 |
| Travel and Lodging | $25,390.91 |
| Food and Beverage | $11,015.77 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $752,862.12 | 2019-2025 | Journey II, Or3o Dual Mobility, Real Intelligence |
| Bone Support INC. | $17,015.25 | 2019-2025 | Ceramentbone Void Filler, Cerament G |
| Orthalign INC | $5,810.46 | 2019-2025 | Orthalign Plus |
| Stryker Corporation | $3,862.64 | 2019-2025 | Makoplasty, Alphavent, Tritanium |
| Heron Therapeutics, INC. | $3,122.02 | 2019 | |
| Heraeus Medical, LLC. | $3,017.53 | 2019-2023 | Palacos |
| Zimmer Biomet Holdings, INC. | $1,260.97 | 2019-2025 | Rosa, Oxford |
| Encore Medical, LP | $836.08 | 2022-2023 | Djo Surgical |
| Onkos Surgical, INC. | $420.83 | 2019-2025 | Eleos Limb Salvage System |
| Medacta USA, INC. | $266.91 | 2024-2025 | Mypao, Quadra, Mecta |
| Medical Device Business Services, INC. | $244.11 | 2025 | Stratafix |
| Davol INC. | $180.80 | 2023-2024 | Phasix Mesh |
| Organogenesis INC. | $122.80 | 2019 | |
| Engage Uni, LLC | $114.00 | 2021 | |
| Depuy Synthes Sales INC. | $112.41 | 2023 | Attune |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $84.82 | 2025 | Vistaseal |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Duncan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.